Quantum Biopharma Files 6-K Report
Ticker: QNTM · Form: 6-K · Filed: 2026-04-02T08:30:03-04:00
Sentiment: neutral
Topics: foreign-issuer, regulatory-filing, press-release
TL;DR
Quantum Biopharma filed a 6-K on 4/2/26 with a press release. Toronto HQ.
AI Summary
Quantum Biopharma Ltd. filed a Form 6-K on April 2, 2026, reporting information as a foreign issuer. The filing includes a press release as Exhibit 99.1. The company's mailing and business address is 55 University Avenue, Suite 1003, Toronto, Ontario, Canada.
Why It Matters
This filing provides updated information for Quantum Biopharma Ltd. as a foreign issuer, which is important for investors tracking the company's regulatory disclosures.
Risk Assessment
Risk Level: low — A 6-K filing is a routine report for foreign issuers and does not inherently indicate significant new risks.
Key Players & Entities
- Quantum Biopharma Ltd. (company) — Filer
- 0001771885 (company) — CIK Number
- 55 UNIVERSITY AVENUE, SUITE 1003 TORONTO Ontario, Canada M5J 2H7 (company) — Mailing and Business Address
- April 2, 2026 (date) — Filing Date
FAQ
What type of SEC filing is this?
This is a Form 6-K, which is a report of a foreign issuer.
When was this filing made?
The filing date was April 2, 2026.
What is the company's primary business classification?
The company is classified under SIC code 2834, Pharmaceutical Preparations.
Where is Quantum Biopharma Ltd. located?
The company's mailing and business address is 55 University Avenue, Suite 1003, Toronto, Ontario, Canada.
What document is included as an exhibit?
Exhibit 99.1, a press release, is included with the filing.
From the Filing
EDGAR Filing Documents for 0001171843-26-002207 This page uses Javascript. Your browser either doesn't support Javascript or you have it turned off. To see this page as it is meant to appear please use a Javascript enabled browser. SEC.gov EDGAR Latest Filings Filings search tools Filing Detail SEC Home » Company Search » Current Page Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]: SEC Accession No. 0001171843-26-002207 Filing Date 2026-04-02 Accepted 2026-04-02 08:30:03 Documents 2 Period of Report 2026-04-02 Document Format Files Seq Description Document Type Size 1 FORM 6-K f6k_040126.htm 6-K 6005 2 PRESS RELEASE exh_991.htm EX-99.1 5452 Complete submission text file 0001171843-26-002207.txt 12688 Mailing Address 55 UNIVERSITY AVENUE, SUITE 1003 TORONTO Ontario, Canada M5J 2H7 Business Address 55 UNIVERSITY AVENUE, SUITE 1003 TORONTO Ontario, Canada M5J 2H7 (416) 854-8884 Quantum Biopharma Ltd. (Filer) CIK : 0001771885 (see all company filings) EIN. : 000000000 | State of Incorp.: A6 | Fiscal Year End: 1231 Type: 6-K | Act: 34 | File No.: 001-39152 | Film No.: 26830735 SIC : 2834 Pharmaceutical Preparations (CF Office: 03 Life Sciences)